D-0950-2016 Class III Terminated
FDA drug recall D-0950-2016 was initiated by Taro Pharmaceuticals U.S.A., Inc. on Mar 31, 2016 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jun 6, 2018). Affected quantity: 62,800 Tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 8, 2016
- Initiation Date
- Mar 31, 2016
- Termination Date
- Jun 6, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 62,800 Tubes
Product description
¿Topicort (desoximetasone) Cream USP, 0.05%, Packaged in 5 g Tubes, Professional Sample Only, Rx Only. Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: TaroPharma a division of Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC: 51672-5205-5.
Reason for recall
Subpotent Drug
Distribution pattern
U.S. Including: CA, CT, MA, MD, NY, NJ, OK, TX, and WA
Code information
Lot # A5192-18338, Expiry: 12/2016
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0950-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026